BACKGROUND: Rib @entity174 after @entity764 are a common injury; however, they carry a significant morbidity and mortality risk. The impact of @entity174 in the 65-year and older @entity1 population has been well documented as have the mortality and @entity55 rates. We hypothesize that @entity1 65 years and older receiving @entity17339 ( @entity17339 ) have decreased mortality, complication rates, and an accelerated return to normal functional states when compared with controls. METHODS: With institutional review board approval, a retrospective review analyzed @entity1 65 years and older with @entity174 admitted from 2009 to 2015 receiving @entity17339 ( @entity17339 group) (n = 23) compared to nonoperative, injury-matched controls admitted from 2003 to 2008 (NO group) (n = 50). @entity1 were followed prospectively with regard to lifestyle and functional satisfaction. Independent variables analyzed included Injury Severity Score (ISS), number of @entity174 , mortalities, hospital days, intensive care unit days, @entity55 development, @entity1576 , readmission rates, need for and length of rehabilitation stay time. Comparisons were by    tests/ @entity16043 's exact tests, Student's t tests and Wilcoxon rank sum tests. RESULTS: From 2003 to 2008, 50 NO @entity1 were admitted with ages ranging 65 to 97 years, average ISS of 18.47 (14.28-22.66) versus ages ranging from 63 to 89 years, average ISS of 20.71 (15.7-25.73) for the @entity17339 group (n = 23). Average hospital days were 16.76 (10.35-23.18) and 18.36 (13.61-23.11) in the NO and @entity17339 groups, respectively. Average intensive care unit days were 11.65 (6.45-16.85) and 8.29 (5.31-11.26) days in the NO and @entity17339 groups, respectively. Four respiratory readmissions, two deaths, seven @entity55 , seven @entity1143 , and 19 recurrent pneumothoraces were encountered in the NO group versus 0 in the @entity17339 group (p < 0.001). An equal percentage of @entity1 in both groups entered rehabilitation facilities with average stay time of 18.5 and 28.53 days for the @entity17339 and NO groups, respectively. CONCLUSION: @entity17339 in the 65-year and older @entity130 population demonstrates a measurable decrease in mortality and @entity1576 , improves respiratory mechanics, and permits an accelerated return to functioning state. LEVEL OF EVIDENCE: Therapeutic/care management study, level IV.

Rib @entity174 fixation in the 65 years and older population: A paradigm shift in management strategy at a Level I XXXX center.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity1143 :: ('MESH:D010996', 'Disease') :: ['pleural-effusions'] @entity174 :: ('MESH:D050723', 'Disease') :: ['fractures', 'rib fractures'] @entity55 :: ('MESH:D011014', 'Disease') :: ['pneumonia', 'pneumonias'] @entity764 :: ('MESH:D013898', 'Disease') :: ['chest wall trauma'] @entity1576 :: ('MESH:D012131', 'Disease') :: ['respiratory complications'] @entity16043 :: ('76720', 'Species') :: ['Fisher'] @entity17339 :: ('MESH:C537613', 'Disease') :: ['RP', 'rib plating'] @entity130 :: ('MESH:D014947', 'Disease') :: ['trauma']
@entity130 :: (MESH:D014947,Disease) :: ['trauma']
